weight loss semaglutide first month Your First 3 Months on

The trial enrolled 101 participants from Canada, Germany, Spain, and the Netherlands

Yang et al., 2013

Semaglutide (PMC, 2025) Real-world HbA1c and weight outcomes: Tirzepatide vs

For instance, post hoc analyses from SURMOUNT-1 through SURMOUNT-4 [73] and from across the SURPASS program [74] showed that weight reduction with tirzepatide was neither solely nor fully associated with reported gastrointestinal adverse events, challenging the traditional assumption that nausea and vomiting are significant mediators of weight reduction

Anaesthetists are concerned about food remaining in the stomach during general anaesthesia due to the risk of aspiration